ADC Therapeutics Statistics
Total Valuation
ADCT has a market cap or net worth of $189.51 million. The enterprise value is $376.40 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ADCT has 96.69 million shares outstanding. The number of shares has increased by 12.44% in one year.
| Current Share Class | 96.69M |
| Shares Outstanding | 96.69M |
| Shares Change (YoY) | +12.44% |
| Shares Change (QoQ) | +9.54% |
| Owned by Insiders (%) | 6.38% |
| Owned by Institutions (%) | 35.09% |
| Float | 76.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.62 |
| Forward PS | 2.50 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.92
| Current Ratio | 4.92 |
| Quick Ratio | 4.41 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.70 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -21.17% |
| Return on Capital (ROIC) | -26.01% |
| Revenue Per Employee | $258,091 |
| Profits Per Employee | -$774,270 |
| Employee Count | 274 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 6.73 |
Taxes
In the past 12 months, ADCT has paid $43.66 million in taxes.
| Income Tax | 43.66M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.47% in the last 52 weeks. The beta is 1.53, so ADCT's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | +17.47% |
| 50-Day Moving Average | 2.51 |
| 200-Day Moving Average | 3.31 |
| Relative Strength Index (RSI) | 43.65 |
| Average Volume (20 Days) | 1,757,271 |
Short Selling Information
The latest short interest is 4.12 million, so 4.26% of the outstanding shares have been sold short.
| Short Interest | 4.12M |
| Short Previous Month | 3.16M |
| Short % of Shares Out | 4.26% |
| Short % of Float | 5.37% |
| Short Ratio (days to cover) | 2.97 |
Income Statement
In the last 12 months, ADCT had revenue of $70.72 million and -$212.15 million in losses. Loss per share was -$2.32.
| Revenue | 70.72M |
| Gross Profit | -59.86M |
| Operating Income | -138.20M |
| Pretax Income | -170.29M |
| Net Income | -212.15M |
| EBITDA | -136.87M |
| EBIT | -138.20M |
| Loss Per Share | -$2.32 |
Full Income StatementBalance Sheet
The company has $274.27 million in cash and $454.40 million in debt, giving a net cash position of -$180.12 million or -$1.86 per share.
| Cash & Cash Equivalents | 274.27M |
| Total Debt | 454.40M |
| Net Cash | -180.12M |
| Net Cash Per Share | -$1.86 |
| Equity (Book Value) | -171.95M |
| Book Value Per Share | -1.78 |
| Working Capital | 265.33M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$133.62 million and capital expenditures -$1.10 million, giving a free cash flow of -$134.72 million.
| Operating Cash Flow | -133.62M |
| Capital Expenditures | -1.10M |
| Free Cash Flow | -134.72M |
| FCF Per Share | -$1.39 |
Full Cash Flow StatementMargins
Gross margin is -84.64%, with operating and profit margins of -195.42% and -300.00%.
| Gross Margin | -84.64% |
| Operating Margin | -195.42% |
| Pretax Margin | -238.26% |
| Profit Margin | -300.00% |
| EBITDA Margin | -193.54% |
| EBIT Margin | -195.42% |
| FCF Margin | n/a |
Dividends & Yields
ADCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.44% |
| Shareholder Yield | -12.44% |
| Earnings Yield | -108.09% |
| FCF Yield | -68.64% |
Analyst Forecast
The average price target for ADCT is $8.00, which is 308.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 308.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 28.98% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ADCT has an Altman Z-Score of -5.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.76 |
| Piotroski F-Score | 2 |